Home
Live Updates
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors - Eledon Pharma (NASDAQ:ELDN) : comparemela.com
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors - Eledon Pharma (NASDAQ:ELDN)
IRVINE, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced the appointment of Allan Douglas Kirk, M.D., Ph.D., to its Board of Directors. Dr. Kirk is
Related Keywords
United States ,
California ,
Irvine ,
American ,
David Alexandrec Gros ,
Stephen Jasper ,
Davidc Sabiston Jr ,
Allan Douglas Kirk ,
Berry Company Public Relations ,
Duke Transplant Center ,
Gilmartin Group ,
Duke University School Of Medicine ,
Exchange Commission ,
Old Dominion University ,
Linkedin ,
Twitter ,
Department Of Surgery ,
Eledon Pharmaceuticals ,
Duke University ,
Eledon Pharmaceuticals Inc ,
Duke University School ,
Integrative Immunobiology ,
Eledon Chief Executive ,
Transplantation Branch ,
National Institute ,
Kidney Diseases ,
Duke Innovation ,
American Journal ,
Old Dominion ,
Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.